XML 29 R13.htm IDEA: XBRL DOCUMENT
v3.22.4

Discontinued Operations | 12 Months Ended
--- | ---
Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract] |
Discontinued Operations | Discontinued Operations Cryobiological Products Divestiture On October 1, 2020, we closed on the sale of our cryobiological products business, which was formerly within our D&S West segment prior to the realignment of our segment reporting structuring in the fourth quarter of 2020, to Cryoport, Inc. (NASDAQ: CYRX) for net cash proceeds of $317.5, inclusive of the base purchase price of $320.0 less estimated closing adjustments of $2.5 (the “Cryobiological Divestiture”). The strategic decision to divest of our cryobiological products business reflected our strategy and capital allocation approach to focus on our core capabilities and offerings. We recorded a gain on the Cryobiological Divestiture of $224.2, net of taxes of $25.2, for the year ended December 31, 2020. Interest expense of $7.4 was allocated to discontinued operations for the year ended December 31, 2020, based on interest on our term loan due June 2024 that was required to be repaid as a result of the Cryobiological Divestiture. Summarized Financial Information of Discontinued Operations The following table represents income from discontinued operations, net of tax:
| Year Ended December 31, |
| 2022 |  | 2020 |
Sales | $ | — |  |  | $ | 59.9 |  |
Cost of sales | — |  |  | 31.8 |  |
Selling, general and administrative expenses | 74.8 |  |  | 7.8 |  |
Operating (loss) income (1) (2) | (74.8) |  |  | 20.3 |  |
Interest expense, net | — |  |  | 7.4 |  |
Other expense (income), net | — |  |  | (0.8) |  |
(Loss) income before income taxes | (74.8) |  |  | 13.7 |  |
Income tax benefit | (17.2) |  |  | (1.3) |  |
(Loss) income from discontinued operations before gain on sale of business | (57.6) |  |  | 15.0 |  |
Gain on sale of business, net of taxes (3) | — |  |  | 224.2 |  |
(Loss) income from discontinued operations, net of tax (4) | $ | (57.6) |  |  | $ | 239.2 |  |
_______________ (1)Includes depreciation expense of $0.7 for the year ended December 31, 2020. (2)See Note 21, “Commitments and Contingencies,” for further information related to other expense (income), net for the year ended December 31, 2022. (3)Gain on sale of business is net of taxes of $25.2 for the year ended December 31, 2020. (4)There was no income or cash flows from discontinued operations for the year ended December 31, 2021. The following table presents a summary of cash flows related to discontinued operations for the following period:
| Year Ended December 31,
| 2020
Net cash provided by: |
Operating activities | $ | 18.3 |
Investing activities | 316.7 |
Net cash provided by discontinued operations | $ | 335.0 |

X
- References No definition available. + Details
Name: | us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -URI https://asc.fasb.org/topic&trid=2155823 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -URI https://asc.fasb.org/subtopic&trid=2122178 + Details
Name: | us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration